Heparin-binding EGF-like growth factor: A juxtacrine growth factor

Cytokine and Growth Factor Reviews

Volumn 11, Issue 4, 2000, Pages 335-344

  Iwamoto, Ryo ^a   Mekada, Eisuke ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Ectodomain shedding; EGF family; EGF receptor; HB EGF; Juxtacrine

Indexed keywords

CELL SURFACE RECEPTOR; DIPHTHERIA TOXIN RECEPTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; HEPARIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; MEMBRANE PROTEIN; PROTEIN PRECURSOR;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL GROWTH; COMPLEX FORMATION; DROSOPHILA; FEMALE; HUMAN; IN VITRO STUDY; NIDATION; NONHUMAN; PREGNANCY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALIA;

EID: 0033830725     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(00)00013-7     Document Type: Review

References (73)

1. Membrane-anchored growth factors
2. Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor α to epidermal growth factor receptors promotes cell proliferation
3. Expression of the TGFα integral membrane precursor induces transformation of NRK cells
4. Transmembrane, TGF-α precursors activate EGF/TGF-α receptors
5. The TGF-α precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction
6. Steel-Dickie mutation encodes a c-Kit ligand lacking transmembrane and cytoplasmic domains
7. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in Sld mutant
8. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2
9. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity
10. Down regulation of Fas ligand by shedding
11. Secreted Spitz triggers the DER signaling pathway and is a limiting component in embryonic ventral ectoderm determination
12. Processing of the Notch ligand delta by the metalloprotease Kuzubanian
13. Bi-directional signaling through EPH-family receptor Nuk and its transmembrane ligands
14. Tyrosine phosphorylation of transmembrane ligands for Eph receptors
15. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
16. Heparin-binding EGF-like growth factor
17. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation
18. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: Conversion from juxtacrine to paracrine growth factor activity
19. A metalloprotease-disintegrin, ADAM9/MDC9/meltrin-γ, and PKC-δ are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor
20. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: Dependence on interactions with cell surface heparan sulfate
21. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin
22. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor
23. Identification of diphtheria toxin receptor and a non-proteinous diphtheria toxin-binding molecule in Vero cell membrane
24. Purification of diphtheria toxin receptor from Vero cells
25. The diphtheria toxin receptor
26. Expression cloning of a diphtheria toxin receptor: Identity with a heparin-binding EGF-like growth factor precursor
27. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity
28. Structure-function analysis of the diphtheria toxin receptor toxin binding site by site-directed mutagenesis
29. Diphtheria toxin and related proteins: Isolation and properties of mutant proteins serologically related to diphtheria toxin
30. An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor
31. The 27-kD diphtheria toxin receptor-associated protein (DRAP27) from Vero cells is the monkey homologue of human CD9 antigen: Expression of DRAP27 elevates the number of diphtheria toxin receptors on toxin-sensitive cells
32. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity
33. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin α3β1 at cell-cell contact sites
34. Integrin-dependent EGF receptor activation at cell-cell contact sites
35. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF
36. The membrane protein CD9/DRAP27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor
37. Contact-dependent growth inhibition and apoptosis of epidermal growth factor (EGF) receptor-expressing cells by the membrane-anchored form of heparin-binding EGF-like growth factor
38. Role of dimerization of the membrane-associated growth factor kit ligand in juxtacrine signaling the SL(17H) mutation affects dimerization and stability - Phenotypes in hematopoiesis
39. Membrane-anchored heparin-binding EGF-like growth factor acts as a tumor survival factor in hepatoma cell line
40. The membrane-bound form of heparin-binding epidermal growth factor-like growth factor promotes survival of cultured renal epitherial cells
41. Selective cleavage of the herregulin receptor ErbB-4 by protein kinase C activation
42. Shedding of the lymphocyte L-selectin adhesion molecule is inhibited by a hydroxamic acid-based protease inhibitor. Identification with an L-selectin-alkalin phosphatase reporter
43. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation
44. ECM and cell surface proteolysis: Regulating cellular ecology
45. Cleavage of amyloid β peptide during constitutive processing of its precursor
46. Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): Studies on the cell-associated receptor cleaved by a metalloprotease in phorbolester-treated cells
47. The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading
48. Ectodomain shedding of TGF-a and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades
49. EGF receptor transactivation by G-protein-coupled receptors required metalloproteinase cleavage of proHB-EGF
50. Signal characteristics of G-protein-transactivated EGF receptor
51. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
52. Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor
53. Heparin-binding EGF-like growth factor: Characterization of rat and mouse cDNA clones, protein domain conservation across species, and transcript expression in tissues
54. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface
55. Regulation of heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adult rat cardiac myocytes
56. Distribution of heparin-binding EGF-like growth factor protein and mRNA in the normal rat kidneys
57. Blastocyst's state of activity determines the 'window' of implantation in the receptive mouse uterus
58. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: A possible ligand for interaction with blastocyst EGF-receptor in implantation
59. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor
60. Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbBl: A possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation
61. Aberrent neural and cardiac development in mice lacking the ErbB4 neuregulin receptor
62. Epitherial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
63. Strain-dependent epithelial defects in mice lacking the EGF receptor
64. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
65. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor
66. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury
67. Production of heparin-binding epidermal growth factor-like growth factor (HB-EGF) at sites of thermal injury in pediatric patients
68. + T cells
69. Wound fluid-derived heparin-binding EGF-like growth factor (HB-EGF) is synergistic with insulin-like growth factor-I for Balb/MK keratinocyte proliferation
70. Regulation of heparin binding-epidermal growth factor like growth factor gene expression by LDL and oxidized-LDL in rat mesangial cells
71. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by protein kinase C activators
72. Increased expression of heparin binding epidermal growth-factor-like growth factor mRNA in the kidney of streptozotocin-induced diabetic rats
73. Induction of heparin-binding epidermal growth factor-like growth factor mRNA in rat kidney after acute injury